Registration
Info
AGI Expert Masterclass: Genetics, Disease Mechanisms and Trial Readiness in SCAs
The first AGI Expert Masterclass on Spinocerebellar Ataxias (SCAs), held online on 21–23 April 2026, brings together leading international experts to address genetics, disease mechanisms, and trial readiness in SCAs. The program delivers advanced, up-to-date content with a strong emphasis on research and basic science, covering genetic diagnostics, pathophysiology, therapeutic strategies, and clinical, digital, imaging, and molecular outcomes relevant for clinical trials. This masterclass is designed for clinicians and basic researchers working in ataxias and assumes prior foundational knowledge of ataxia characteristics, as gained through NAF/MDS training or comparable clinical or research experience.
Program (Time in CEST/Paris and EDT/Boston)
Day 1: Tue, 21 Apr 2026
Session 1 – Disease Groups - Focusing on SCAs
Introduction (Thomas Klockgether, Bonn, Germany), 3-3:10 pm CEST, 9-9:10 am EDT
Polyglutamine SCAs (Laura Jardim, Porto Alegre, Brazil, tbc), 3:10–3:35 pm CEST, 9:10-9:35 am EDT
Intronic Expansions/ Repeats (tbc), 3:35-4 pm CEST, 9:35-10 am EDT
Non-Repeat Disease (Joana Damasio, Porto, Portugal), 4-4:30 pm CEST, 10-10:30 am EDT
Session 2 – Genetic Diagnostics, incl. Novel Technologies and Genetic Testing
Technology (long read/ short read genome sequencing) (Alex Hoischen, Nijmegen, The Netherlands), 4:45-5:15 pm CEST, 10:45-11:15 am EDT
Diagnostic Strategies (Tobias Haack, Tuebingen,Germany), 5:15-5:45 pm CEST, 11:15-11:45 am EDT
Pre-Symptomatic Testing (Alexis Brice, Paris, tbc), 5:45-6:15 pm CEST, 11:45 am - 12:15 pm EDT
Day 2: Wed, 22 Apr 2026
Session 1 – Disease Mechanisms
Polyglutamine Disorders (Thorsten Schmidt, Tuebingen, Germany), 3-3:30 pm CEST, 9-9:30 am EDT
Ion Channel Involvement and Therapeutic Approaches (Vikram Shakkottai, Dallas, USA), 3:30-4 pm CEST, 9:30-10 am EDT
Non-Repeat Ataxias (David Pellerin, Montreal, Canada), 4-4:30 pm CEST, 10-10:30 am EDT
Session 2 – Therapies
ASO Therapies (Hayley McLaughlin, Ann Arbor, USA), 4:45-5:15 pm CEST, 10:45-11:15 am EDT
Supportive Treatments (Sheng-Han Kuo, New York, USA), 5:15-5:45 pm CEST, 11:15-11:45 am EDT
Transcranial Stimulation (Roderick Maas, Nijmegen, The Netherlands), 5:45-6:15 pm CEST, 11:45 am - 12:15 pm EDT
Day 3: Thur, 23 Apr 2026
Session 1 – Outcomes - Clinical and Digital
15:00 – 15:30: Clinical Scales (Marcus Grobe-Einsler, Bonn, Germany), 3-3:30 pm CEST, 9-9:30 am EDT
15:30 – 16:00: PROMs (Jeremy Schmahmann, Boston, USA), 3:30-4 pm CEST, 9:30-10 am EDT
16:00 – 16:30: Digital Markers (Winfried Ilg, Tuebingen, Germany), 4-4:30 pm CEST, 10-10:30 am EDT
Session 2 – Outcomes - Imaging and Molecular
Imaging (Gulin Oz, Minneapolis, USA), 4:45-5:15 pm CEST, 10:45-11:15 am EDT
Fluid Biomarkers (Giulia Coarelli, Paris, France), 5:15-5:45 pm CEST, 11:15-11:45 am EDT
Trial Readiness of Biomarkers (Jennifer Faber, Bonn, Germany), 5:45-6:15 pm CEST, 11:45 am - 12:15 pm EDT
Wrap-Up (Thomas Klockgether, Bonn, Germany)